A Randomised Crossover Trial: The Effect of Inulin on Glucose Homeostasis in Subtypes of Prediabetes

Annals of Nutrition and Metabolism

Volumn 68, Issue 1, 2016, Pages 26-34

  Guess, Nicola D ^a,b   Dornhorst, Anne ^b   Oliver, Nick ^b   Frost, Gary S ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

Author keywords

Diabetes prevention; Fermentable carbohydrate; Glucagon like peptide 1; Insulin secretion; Insulin sensitivity; Nutrition; Prediabetes

Indexed keywords

FATTY ACID; GLUCAGON LIKE PEPTIDE 1; GLUCOSE BLOOD LEVEL; INSULIN; INULIN;

AGED; BLOOD; BODY MASS; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIABETES MELLITUS, TYPE 2; DOUBLE BLIND PROCEDURE; FEMALE; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; MALE; METABOLISM; MIDDLE AGED; PREDIABETIC STATE; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR;

AGED; BLOOD GLUCOSE; BODY MASS INDEX; CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 2; DOUBLE-BLIND METHOD; FATTY ACIDS, NONESTERIFIED; FEMALE; GLUCAGON-LIKE PEPTIDE 1; HOMEOSTASIS; HUMANS; INSULIN; INSULIN RESISTANCE; INULIN; MALE; MIDDLE AGED; PREDIABETIC STATE; RISK FACTORS;

EID: 84955677694     PISSN: 02506807     EISSN: 14219697     Source Type: Journal    
DOI: 10.1159/000441626     Document Type: Article

References (45)

1. de Vegt F, Dekker JM, Jager A, Hienkens E, Kostense PJ, Stehouwer CD, Nijpels G, Bouter LM, Heine RJ: Relation of impaired fasting and postload glucose with incident type 2 diabetes in a Dutch population: the hoorn study. JAMA 2001;285:2109-2113.
2. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM; Diabetes Prevention Program Research Group: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393-403.
3. Whittemore R, Melkus G, Wagner J, Dziura J, Northrup V, Grey M: Translating the diabetes prevention program to primary care: a pilot study. Nurs Res 2009;58:2-12.
4. Diabetes Prevention Program (DPP) Research Group: The diabetes prevention program (DPP): description of lifestyle intervention. Diabetes Care 2002;25:2165-2171.
5. Sleeth ML, Thompson EL, Ford HE, Zac-Varghese SE, Frost G: Free fatty acid receptor 2 and nutrient sensing: a proposed role for fibre, fermentable carbohydrates and short-chain fatty acids in appetite regulation. Nutr Res Rev 2010;23:135-145.
6. Bodinham CL, Smith L, Wright J, Frost GS, Robertson MD: Dietary fibre improves first-phase insulin secretion in overweight individuals. PLoS One 2012;7:e40834.
7. Robertson MD, Wright JW, Loizon E, Debard C, Vidal H, Shojaee-Moradie F, Russell-Jones D, Umpleby AM: Insulin-sensitizing effects on muscle and adipose tissue after dietary fiber intake in men and women with metabolic syndrome. J Clin Endocrinol Metab 2012;97:3326-3332.
8. Thorburn A, Muir J, Proietto J: Carbohydrate fermentation decreases hepatic glucose output in healthy subjects. Metabolism 1993;42:780-785.
9. Cernea S, Raz I: Therapy in the early stage: incretins. Diabetes Care 2011;34(suppl 2):S264-S271.
10. Zhang F, Tang X, Cao H, Lü Q, Li N, Liu Y, Zhang X, Zhang Y, Cao M, Wan J, An Z, Tong N: Impaired secretion of total glucagon-like peptide-1 in people with impaired fasting glucose combined impaired glucose tolerance. Int J Med Sci 2012;9:574-581.
11. Unwin N, Shaw J, Zimmet P, Alberti KG: Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention. Diabet Med 2002;19:708-723.
12. Festa A, D'Agostino R Jr, Hanley AJ, Karter AJ, Saad MF, Haffner SM: Differences in insulin resistance in nondiabetic subjects with isolated impaired glucose tolerance or isolated impaired fasting glucose. Diabetes 2004;53:1549-1555.
13. Abdul-Ghani MA, Tripathy D, DeFronzo RA: Contributions of beta-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose. Diabetes Care 2006;29:1130-1139.
14. Faerch K, Vaag A, Holst JJ, Hansen T, Jørgensen T, Borch-Johnsen K: Natural history of insulin sensitivity and insulin secretion in the progression from normal glucose tolerance to impaired fasting glycemia and impaired glucose tolerance: the Inter99 study. Diabetes Care 2009;32:439-444.
15. Daud NM, Ismail NA, Thomas EL, Fitzpatrick JA, Bell JD, Swann JR, Costabile A, Childs CE, Pedersen C, Goldstone AP, Frost GS: The impact of oligofructose on stimulation of gut hormones, appetite regulation and adiposity. Obesity (Silver Spring) 2014;22:1430-1438.
16. Pedersen C, Lefevre S, Peters V, Patterson M, Ghatei MA, Morgan LM, Frost GS: Gut hormone release and appetite regulation in healthy non-obese participants following oligofructose intake. A dose-escalation study. Appetite 2013;66:44-53.
17. Hill NR, Oliver NS, Choudhary P, Levy JC, Hindmarsh P, Matthews DR: Normal reference range for mean tissue glucose and glycemic variability derived from continuous glucose monitoring for subjects without diabetes in different ethnic groups. Diabetes Technol Ther 2011;13:921-928.
18. Kreymann B, Williams G, Ghatei MA, Bloom SR: Glucagon-like peptide-1 7-36: a physiological incretin in man. Lancet 1987;2:1300-1304.
19. Robertson MD, Currie JM, Morgan LM, Jewell DP, Frayn KN: Prior short-term consumption of resistant starch enhances postprandial insulin sensitivity in healthy subjects. Diabetologia 2003;46:659-665.
20. Levy JC, Matthews DR, Hermans MP: Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care 1998;21:2191-2192.
21. Maki KC, McKenney JM, Farmer MV, Reeves MS, Dicklin MR: Indices of insulin sensitivity and secretion from a standard liquid meal test in subjects with type 2 diabetes, impaired or normal fasting glucose. Nutr J 2009;8:22.
22. Del Prato S, Tiengo A: The importance of first-phase insulin secretion: implications for the therapy of type 2 diabetes mellitus. Diabetes Metab Res Rev 2001;17:164-174.
23. Polonsky KS, Given BD, Van Cauter E: Twenty-four-hour profiles and pulsatile patterns of insulin secretion in normal and obese subjects. J Clin Invest 1988;81:442-448.
24. Tura A, Kautzky-Willer A, Pacini G: Insulinogenic indices from insulin and C-peptide: comparison of beta-cell function from OGTT and IVGTT. Diabetes Res Clin Pract 2006;72:298-301.
25. Freeland KR, Wilson C, Wolever TM: Adaptation of colonic fermentation and glucagon-like peptide-1 secretion with increased wheat fibre intake for 1 year in hyperinsulinaemic human subjects. Br J Nutr 2010;103:82-90.
26. Weickert MO, Möhlig M, Schöfl C, Arafat AM, Otto B, Viehoff H, Koebnick C, Kohl A, Spranger J, Pfeiffer AF: Cereal fiber improves whole-body insulin sensitivity in overweight and obese women. Diabetes Care 2006;29:775-780.
27. Schneider AR, Jepp K, Murczynski L, Biniek U, Stein J: The inulin hydrogen breath test accurately reflects orocaecal transit time. Eur J Clin Invest 2007;37:802-807.
28. Cani PD, Hoste S, Guiot Y, Delzenne NM: Dietary non-digestible carbohydrates promote L-cell differentiation in the proximal colon of rats. Br J Nutr 2007;98:32-37.
29. Elliott RM, Morgan LM, Tredger JA, Deacon S, Wright J, Marks V: Glucagon-like peptide-1 (7-36)amide and glucose-dependent insulinotropic polypeptide secretion in response to nutrient ingestion in man: acute post-prandial and 24-h secretion patterns. J Endocrinol 1993;138:159-166.
30. Robertson MD, Bickerton AS, Dennis AL, Vidal H, Frayn KN: Insulin-sensitizing effects of dietary resistant starch and effects on skeletal muscle and adipose tissue metabolism. Am J Clin Nutr 2005;82:559-567.
31. Carnevale Schianca GP, Rossi A, Sainaghi PP, Maduli E, Bartoli E: The significance of impaired fasting glucose versus impaired glucose tolerance: importance of insulin secretion and resistance. Diabetes Care 2003;26:1333-1337.
32. Luo J, Rizkalla SW, Alamowitch C, Boussairi A, Blayo A, Barry JL, Laffitte A, Guyon F, Bornet FR, Slama G: Chronic consumption of short-chain fructooligosaccharides by healthy subjects decreased basal hepatic glucose production but had no effect on insulin-stimulated glucose metabolism. Am J Clin Nutr 1996;63:939-945.
33. Topping DL, Clifton PM: Short-chain fatty acids and human colonic function: roles of resistant starch and nonstarch polysaccharides. Physiol Rev 2001;81:1031-1064.
34. Malin SK, Gerber R, Chipkin SR, Braun B: Independent and combined effects of exercise training and metformin on insulin sensitivity in individuals with prediabetes. Diabetes Care 2012;35:131-136.
35. Engberg S, Glümer C, Witte DR, Jørgensen T, Borch-Johnsen K: Differential relationship between physical activity and progression to diabetes by glucose tolerance status: the Inter99 study. Diabetologia 2010;53:70-78.
36. Saito T, Watanabe M, Nishida J, Izumi T, Omura M, Takagi T, Fukunaga R, Bandai Y, Tajima N, Nakamura Y, Ito M; Zensharen Study for Prevention of Lifestyle Diseases Group: Lifestyle modification and prevention of type 2 diabetes in overweight Japanese with impaired fasting glucose levels: a randomized controlled trial. Arch Intern Med 2011;171:1352-1360.
37. Robertson MD, Bickerton AS, Dennis AL, Vidal H, Frayn KN: Insulin-sensitizing effects of dietary resistant starch and effects on skeletal muscle and adipose tissue metabolism. Am J Clin Nutr 2005;82:559-567.
38. Bodinham CL, Smith L, Thomas EL, Bell JD, Swann JR, Costabile A, Russell-Jones D, Umpleby AM, Robertson MD: Efficacy of increased resistant starch consumption in human type 2 diabetes. Endocr Connect 2014;3:75-84.
39. Luo J, Van Yperselle M, Rizkalla SW, Rossi F, Bornet FR, Slama G: Chronic consumption of short-chain fructooligosaccharides does not affect basal hepatic glucose production or insulin resistance in type 2 diabetics. J Nutr 2000;130:1572-1577.
40. Muir JG, Yeow EG, Keogh J, Pizzey C, Bird AR, Sharpe K, O'Dea K, Macrae FA: Combining wheat bran with resistant starch has more beneficial effects on fecal indexes than does wheat bran alone. Am J Clin Nutr 2004;79:1020-1028.
41. Venter CS, Vorster HH, Cummings JH: Effects of dietary propionate on carbohydrate and lipid metabolism in healthy volunteers. Am J Gastroenterol 1990;85:549-553.
42. Todesco T, Rao AV, Bosello O, Jenkins DJ: Propionate lowers blood glucose and alters lipid metabolism in healthy subjects. Am J Clin Nutr 1991;54:860-865.
43. Laurent C, Simoneau C, Marks L, Braschi S, Champ M, Charbonnel B, Krempf M: Effect of acetate and propionate on fasting hepatic glucose production in humans. Eur J Clin Nutr 1995;49:484-491.
44. Parnell JA, Reimer RA: Weight loss during oligofructose supplementation is associated with decreased ghrelin and increased peptide YY in overweight and obese adults. Am J Clin Nutr 2009;89:1751-1759.
45. Abrams SA, Griffin IJ, Hawthorne KM, Ellis KJ: Effect of prebiotic supplementation and calcium intake on body mass index. J Pediatr 2007;151:293-298.